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Abstract  
 
Acute and chronic toxicities of the water extract from the dried fruits of Terminalia bellerica (Gaertn.) Roxb. were 
assessed in both female and male rats. For the study of acute toxicity, a single oral administration of the water extract at a 
dose of 5,000 mg/kg body weight (10 female, 10 male) was performed and the results showed no signs of toxicity such as 
general behavior changes, morbidity, mortality, changes on gross appearance or histopathological changes of the internal 
organs of rats. The study of chronic toxicity was determined by oral feeding both female and male rats (10 female, 10 male) 
daily with the test substance at the dose of 300, 600 and 1,200 mg/kg body weight continuously for 270 days. The 
examinations of signs of toxicity showed no abnormalities in the test groups compared to the controls. In addition, these rats 
were analyzed for final body and organ weights, necropsy, as well as hematological, blood chemical and histopathological 
parameters. Taken together, the water extract from the dried fruits of T. bellerica did not cause acute or chronic toxicities in 
either female or male rats.  
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Introduction  
 
Terminalia bellerica (Gaertn.) Roxb. is an indigenous plant in Southeast Asia and Thailand. It is a plant in the 
family Combretaceae and commonly known as “Sa Maw Phi Phek” in Thai name (Smitinand, 2001). T. bellerica has been 
extensively used in Thai traditional medicine for laxative, carminative, astringent, expectorant and tonic (Department of 
Medical Sciences, Ministry of Public Health 2000). The pharmacological activities of T. bellerica have been shown to 
display a wide spectrum such as antibacterial (Elizabeth 2005; Ahmad et al., 1998), antifungal (Valsaraj et al., 1997), 
antioxidant (Bajpai et al., 2005), and anti-HIV-1 reverse transcriptase (el-Mekkawy et al., 1995). Only limited toxicity data 
of these plants have been reported. The acute toxicity study of the alcoholic extract from fruits of T. bellerica showed no 
toxic effects in mice (Mokkhasmit et al., 1971) or rats (Thanaporn et al., 2006). In subchronic toxicity study, the 95% 
ethanolic extract from its fruits in rats presented no toxic effects (Thanaporn et al., 2006). Nevertheless, acute and chronic 
toxicity studies of the water extract has not yet been studied. Consequently, the aim of this study was to evaluate the acute 
and chronic toxicity of the water extract of T. bellerica in rats. 
 
Materials and methods 
Plant material 
 
The mature fruits of T. bellerica were collected during September to November from the forest of Wangnumyen 
district, Sakaew province, Thailand. The plant material was identified and the voucher specimen (PBM 02678) was kept at 
Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.  
 
Preparation of T. bellerica water extract (TB extract) 
 
The method of preparation was described. Briefly, 104 kg of T. bellerica dry fruits were boiled for 1 hour and 
filtered. This process was repeated 3 times. The extract is spray dried to remove trace of water. After that, TB extract was 
tested to control quality such as physical appearance, percentage of loss on drying, total ash, acid insoluble ash, microbial 
test, aflatoxin test, heavy metal, and quantity of chemical compounds (percentage of tannins, total carbohydrate, uronic acid, 
and gallic acid), according to Thai herbal pharmacopoeia.  
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Experimental animals  
 
Adult female and male Sprague-Dawley (SD) rats, 8-10 weeks old were obtained from the National Laboratory 
Animal Center, Nakorn Pathom, Thailand. They were housed under standard environmental conditions of temperature at 24 
± 1 C under a 12 h dark-light cycle, and allowed free access to drinking water and standard pellet diet. Rats were deprived 
of food except water 16-18 hour prior the experiments. The Animal Ethics Committee of Faculty of Medicine, Thammasat 
University approved all experimental protocols (No. 0001/2007). 
 
Acute oral toxicity in rats  
 
The single dose acute oral toxicity study was evaluated following the recommendations by OECD (2001) and 
WHO (2000). Ten rats per sex were administrated a single oral dose of TB extract at a dose of 5,000 mg/kg while the control 
group received water vehicle. Body weight, signs of toxicity and mortality were observed after the administration at the first, 
second, fourth and sixth hour and once daily for 14 days. On the 15th day, all rats were sacrificed for necropsy examination.  
 
Chronic oral toxicity in rats   
Experimental design 
 
The chronic 270-day oral toxicity study was evaluated following the advice by OECD (1981) and WHO (2000). 
Female and male rats were randomly divided into five groups (n=10) and received doses of 0, 300, 600 and 1,200 mg/kg of 
TB extract at daily gavage of 1 ml/kg for 270 days while the control group received distilled water vehicle. In the satellite 
group, the extract at the dose of 1,200 mg/kg was given once daily to the fifth group of rats for 270 days, and kept for 
another 28 days post treatment. Changes in general appearance or behavior, signs of toxicity, mortality and the body weight 
changes were monitored daily. At the end of 270 days (satellite group 298 days), all rats were fasted overnight but with free 
access to water and anesthetized for blood collection from common carotid artery for hematological and chemical 
examination. During necropsy, the internal organs and some tissues were dissected, weighed and observed for gross lesions. 
All tissues were preserved in 10% neutral buffered formalin solution for pathological examination. 
 
Hematology and clinical blood chemistry examination 
 
Hematology analysis was performed using an automated hematology analyzer, Sysmex SF-3000. Whole blood 
samples were collected into CBC bottles containing 0.5% ethylenediaminetetraacetic acid (EDTA)-2K for the following 
parameters: red blood cells, hemoglobin concentration, hematocrit, mean corpuscular volume (MCV), mean corpuscular 
hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), platelet, white blood cells, and differential white 
blood cells. Serum from blood samples collected in separator tubes was measured using the COBAS INTEGRA analyzer, 
including glucose, blood urea nitrogen (BUN), creatinine, total protein, albumin, total and direct bilirubins, aspartate 
aminotransferase (AST), alanine aminotransferease (ALT), and alkaline phosphatase (ALP) analyzes.  
 
Gross and histopathological examination 
 
The positions, shapes, sizes and colors of the internal organs were observed. Brain, lung, heart, liver, spleen, 
pancreas, kidney, adrenal gland, small intestine, stomach, muscle, testes and ovaries in every group were weighed and 
preserved in 10% neutral buffered formalin, sectioned and stained with hematoxylin and eosin (H&E). 
 
Statistical analysis 
Results were expressed as mean ± standard error of mean (S.E.M.). Statistical significance was determined by one-
way analysis of variance (ANOVA) and post hoc least-significant difference (LSD) test. The data obtained from acute 
toxicity studies were analyzed using Student’s t-test. P values less than 0.05 were considered significant. 
 
 
Results 
TB extract  
 
The values of quality control and quantity of chemical compounds of TB extract were remained within the normal 
ranges. TB extract contains 34.46% of tannins, 7.98% of gallic acid, 20% of total carbohydrate, and 5.28% of uronic acid. 
The water extract was not contaminated with aflatoxin, pesticide, heavy metal and microbials.  
 
Acute oral toxicity  
 
The toxic signs, mortalities did not occur in control rats or in female and male rats fed with 5,000 mg/kg of TB 
extract, and neither body weight nor internal organ weight of treated rats was significantly changed relative to that of the 
control group. The internal organs of treated rats such as lung, liver, kidney, spleen, adrenal grand, heart, pancreas, brain and 
sex organ showed no pathological abnormality relative to these organs of the control group (data not shown). Therefore, the 
female and male SD rat oral LD50 of TB extract was considered to be more than 5,000 mg/kg.  
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Chronic oral toxicity  
General behavior and body weight  
  
All of the rats fed with TB extract showed normal general behavior, respiratory pattern, cardiovascular signs, 
motor activities, reflexes, and normal change in skin and fur. Moreover, the female treated groups had no significant 
differences in their body weight and body weight gain when compared with the control groups. In the male treated group, the 
body weight and body weight gain showed significant decreases when compared with the control group (Figure 1).  
 
Hematology  
 
The female rats treated with various doses showed no significant difference when compared with the control 
(Table 1). The mean corpuscular volume (MCV) was significantly decreased in the male rats treated with 600 mg/kg (Table 
1). The differential white blood cell count values are listed in Table 2. In female rats, a significant increase in neutrophil and 
a significant decrease in lymphocyte were observed in the satellite group. In male rats, a significant increase in white blood 
cell was observed in the treated groups with 300 and 600 mg/kg. The male rats treated with 600 mg/kg, lymphocyte was 
significantly decreased when compared with the control group. 
 
Clinical blood chemistry 
 
Clinical blood chemistry examination showed an increased glucose level in female rats treated with 300 and 600 
mg/kg, a decrease of albumin, total bilirubin, direct bilirubin, aspartate aminotransferase (AST) and an increase of alkaline 
phosphatase (ALP) levels in the satellite group (Table 3). In the male rats treated with 1,200 mg/kg, results showed an 
increase of total protein while the satellite male group had a significant decrease of blood urea nitrogen (BUN), total 
bilirubin, and direct bilirubin concentrations (Table 3). 
 
Internal organ weight and histopathological examination 
 
Rats receiving TB extract showed normal structure, size, shape, color and texture of internal organs (kidneys, 
livers, adrenals, sex organs, thymus, stomach, intestine, muscle, pancreas, brain and spinal cord). The organ weights of the 
female treated groups were no significant differences when compared with the control group (data not shown). The male 
treatment groups with 600 mg/kg showed a decrease in brain, lung, heart, liver, and kidney weight and a decrease in lung 
heart and spleen weight of male treatment groups with 1,200 mg/kg. The satellite male group showed a significant increase 
in the kidney weight (Table 4).  
 
 
Figure 1 Body weights of rats in the chronic toxicity study of the T. bellerica water extract. *Significantly different from 
control, p<0.05. 
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Table 1: Effect of T. bellerica water extract on the hematological values of female and male rats in the chronic toxicity test   
T. bellerica water extract  
Hematological values 
 
Control 300 mg/kg 600 mg/kg 1,200  mg/kg Satellite 
Female      
Red Blood Cell (x106/l) 7.36 ± 0.05 7.21 ± 0.14 7.43 ± 0.04 7.25 ± 0.08 7.31 ± 0.14 
Hemoglobin (g/dl) 15.40 ± 0.10 15.12 ± 0.22 15.45 ± 0.10 15.10 ± 0.15 15.07 ± 0.26 
Hematocrit (%) 45.40 ± 0.34 44.13 ± 0.92 45.70 ± 0.37 44.30 ± 0.40 45.20 ± 0.80 
MCV (fl) 61.53 ± 0.37 61.05 ± 0.29 61.51 ± 0.38 61.18 ± 0.30 61.95 ± 0.42 
MCH (pg) 20.92 ± 0.13 20.96 ± 0.23 20.85 ± 0.15 20.85 ± 0.09 20.65 ± 0.16 
MCHC (g/dl) 34.00  0.18 34.34 ± 0.35 33.9 ± 0.21 34.05 ± 0.18 33.90 ± 0.57 
Platelet (x105/l) 5.47 ± 0.17 6.12 ± 0.21 5.77 ± 0.13 5.85 ± 0.23 5.84 ± 0.56 
Male      
Red Blood Cell (x106/l) 8.30 ± 0.21 8.56 ± 0.10 8.67 ± 0.10 8.55 ± 0.11 8.57 ± 0.13 
Hemoglobin (g/dl) 16.05 ± 0.23 16.37 ± 0.15 16.19 ± 0.20 16.11 ± 0.23 16.14 ± 0.21 
Hematocrit (%) 49.70 ± 0.73 51.11 ± 0.61 50.40 ± 0.58 50.20 ± 0.80 50.56 ± 0.75 
MCV (fl) 59.84 ± 0.90 59.62 ± 0.43 58.26 ± 0.58 58.67 ± 0.47 59.02 ± 0.17 
MCH (pg) 19.40 ± 0.31 19.09 ± 0.15 18.69 ± 0.22* 18.85 ± 0.20 18.87 ± 0.11 
MCHC (g/dl) 32.43 ± 0.19 32.07 ± 0.27 32.08 ± 0.18 32.14 ± 0.13 31.94 ± 0.20 
Platelet (x105/l) 8.04 ± 0.22 7.80 ± 0.18 7.99 ± 0.19 8.00 ± 0.20 7.51 ± 0.32 
Values are expressed as mean ± S.E.M., n = 10. 
Satellite: a group was treated with oral dose of 1,200 mg/kg body weight/day for 270 days following by no treatment for 28 days. 
* Significantly different from control, p<0.05. 
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Table 2: Effect of T. bellerica water extract on the differential white blood cell count values of female rats in the chronic toxicity test 
T. bellerica water extract  
Hematological values 
 
Control 300 mg/kg 600 mg/kg 1,200  mg/kg Satellite 
Female      
White blood cell (x103/l) 2.75 ± 0.25 2.41 ± 0.19 3.09 ± 0.42 3.09 ± 0.24 3.00 ± 0.47 
Neutrophil (%) 14.50 ± 1.20 16.38 ± 2.15 18.40 ± 2.56 14.00 ± 1.00 26.00 ± 4.13* 
Lymphocyte (%) 71.41 ± 1.66 70.00 ± 2.67 66.50 ± 3.26 69.70 ± 1.20 62.50 ± 4.43* 
Monocyte (%) 9.70 ± 0.84 9.00 ± 1.17 10.80 ± 0.65 10.60 ± 0.56 8.30 ± 0.50 
Eosinophil (%) 4.40 ± 0.86 4.63 ± 0.98 4.30 ± 1.45 5.70 ± 0.80 3.20 ± 0.63 
Basophil (%) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
Male       
White blood cell (x103/l) 4.31 ± 0.55 6.74 ± 0.05* 5.98 ± 0.41* 4.36 ± 0.69 4.22 ± 0.23 
Neutrophil (%) 25.70 ± 5.05 28.89 ± 3.59 31.50 ± 3.43 22.90 ± 2.25 31.33 ± 3.22 
Lymphocyte (%) 65.70 ± 4.00 59.11 ± 3.67 56.10 ± 3.70* 66.00 ± 2.42 57.22 ± 2.52 
Monocyte (%) 9.70 ± 0.21 10.00 ± 1.38 9.40 ± 0.40 8.40 ± 0.70 8.22 ± 0.52 
Eosinophil (%) 2.20 ± 0.20 2.56 ± 0.56 3.10 ± 0.61 2.70 ± 0.76 2.67 ± 0.50 
Basophil (%) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
Values are expressed as mean ± S.E.M., n = 10. 
Satellite: a group was treated with oral dose of 1,200 mg/kg body weight/day for 270 days following by no treatment for 28 days. 
* Significantly different from control, p<0.05. 
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Table 3: Effect of T. bellerica water extract on blood chemical values of female and male rats in the chronic toxicity test    
T. bellerica water extract  
Hematological values 
 
Control 300 mg/kg 600 mg/kg 1,200  mg/kg Satellite 
Female      
Glucose (mg/dl) 114.60 ± 4.16 127.00 ± 4.66* 125.30 ± 1.78* 118.60 ± 2.75 124.20 ± 5.01 
BUN (mg/dl) 19.10 ± 0.62 18.25 ± 3.23 17.90 ± 0.71 19.10 ± 0.82 18.90 ± 0.88 
Creatinine (mg/dl) 0.42 ± 0.02 0.44 ± 0.02 0.41 ± 0.01 0.41 ± 0.02 0.41 ± 0.02 
Total protein (g/dl) 5.86 ± 0.04 5.81 ± 0.06 5.95 ± 0.10 5.82 ± 0.08 5.81 ± 0.09 
Albumin (g/dl) 3.96 ± 0.03 3.94 ± 0.06 4.02 ± 0.07 3.95 ± 0.05 3.74 ± 0.09* 
Total bilirubin (mg/dl) 0.24 ± 0.02 0.21 ± 0.02 0.23 ± 0.03 0.26 ± 0.02 0.16 ± 0.02* 
Direct bilirubin (mg/dl) 0.07 ± 0.02 0.06 ± 0.02 0.07 ± 0.02 0.07 ± 0.02 0.00 ± 0.00* 
AST (U/l) 148.50 ± 10.02 131.25 ± 11.08 125.70 ± 6.29 146.70 ± 13.66 114.60 ± 8.70* 
ALT (U/l) 47.30 ± 4.24 40.13 ± 3.93 39.40 ± 3.39 45.00 ± 4.41 41.30 ± 2.97 
ALP (U/l) 28.30 ± 1.06 30.00 ± 2.18 31.50 ± 2.17 28.60 ± 1.19 37.10 ± 5.21* 
Male      
Glucose (mg/dl) 136.88 ± 4.03 130.63 ± 4.38 143.63 ± 7.09 127.78 ± 3.05 142.44 ± 5.46 
BUN (mg/dl) 20.30 ± 0.62 20.67 ± 0.65 19.30 ± 0.67 19.40 ± 0.62 18.56 ± 0.29* 
Creatinine (mg/dl) 0.36 ± 0.02 0.37 ± 0.02 0.35 ± 0.02 0.31 ± 0.02 0.41 ± 0.02 
Total protein (g/dl) 5.95 ± 0.08 6.14 ± 0.10 6.09 ± 0.08 6.20 ± 0.06* 6.11 ± 0.08 
Albumin (g/dl) 3.63 ± 0.08 3.66 ± 0.07 3.67 ± 0.05 3.77 ± 0.04 3.57 ± 0.06 
Total bilirubin (mg/dl) 0.19 ± 0.01 0.19 ± 0.01 0.18 ± 0.01 0.20 ± 0.00 0.11 ± 0.01* 
Direct bilirubin (mg/dl) 0.07 ± 0.02 0.06 ± 0.02 0.08 ± 0.01 0.09 ± 0.01 0.00 ± 0.00* 
AST (U/l) 147.30 ± 7.25 161.22 ± 21.87 133.40 ± 8.94 138.80 ± 10.41 133.67 ± 7.44 
ALT (U/l) 47.90 ± 3.65 63.22 ± 8.17 48.00 ± 3.54 56.20 ± 8.50 59.22 ± 5.57 
ALP (U/l) 56.30 ± 2.19 57.89 ± 3.13 62.50 ± 2.77 55.10 ± 1.54 52.44 ± 2.44 
Values are expressed as mean ± S.E.M., n = 10. 
Satellite: a group was treated with oral dose of 1,200 mg/kg body weight/day for 270 days following by no treatment for 28 days. 
* Significantly different from control, p<0.05. 
 
Sireeratawong et al., Afr J Tradit Complement Altern Med. (2013) 10(2):223-231 
http://dx.doi.org/10.4314/ajtcam.v10i2.6 
 
229 
229 
Table 4: Effect of T. bellerica water extract on organ weights of female and male rats in the chronic toxicity test  
T. bellerica water extract Organ  
Control 300 mg/kg 600 mg/kg 1,200  mg/kg Satellite 
Female      
Brain 1.95 ± 0.02 1.94 ± 0.03 1.83 ± 0.04* 1.90 ± 0.03 1.91 ± 0.02 
Lung 1.88 ± 0.13 1.72 ± 0.05 1.78 ± 0.12 1.68 ± 0.06 1.60 ± 0.05* 
Heart 1.24 ± 0.05 1.31 ± 0.05 1.17 ± 0.04 1.25 ± 0.05 1.32 ± 0.04 
Liver 9.55 ± 0.44 8.79 ± 0.35 8.48 ± 0.23* 8.73 ± 0.31 8.96 ± 0.41 
Pancreas 1.45 ± 0.06 1.38 ± 0.09 1.40 ± 0.10 1.60 ± 0.10 1.66 ± 0.11 
Spleen 0.90 ± 0.04 0.91 ± 0.03 0.79 ± 0.03* 0.86 ± 0.04 0.91 ± 0.02 
Adrenal 0.03 ± 0.00 0.03 ± 0.00 0.04 ± 0.00 0.03 ± 0.02 0.03 ± 0.00 
Kidney 1.29 ± 0.03 1.27 ± 0.03 1.16 ± 0.02* 1.25 ± 0.03 1.32 ± 0.03 
Ovary 0.07 ± 0.00 0.08 ± 0.00 0.09 ± 0.00 0.06 ± 0.03 0.07 ± 0.00 
Uterus  0.69 ± 0.08 0.86 ± 0.09 0.74 ± 0.06 0.71 ± 0.06 0.63 ± 0.04 
Male      
Brain 2.08 ± 0.04 1.99 ± 0.02 1.96 ± 0.03* 2.01 ± 0.04 2.00 ± 0.03 
Lung 2.76 ± 0.29 2.49 ± 0.12 2.10 ± 0.11* 2.08 ± 0.08* 2.41 ± 0.31 
Heart 1.77 ± 0.04 1.61 ± 0.06* 1.55 ± 0.05* 1.61 ± 0.07* 1.65 ± 0.06 
Liver 14.65 ± 0.41 13.67 ± 0.39 11.95 ± 0.42* 13.56 ± 0.55 15.99 ± 0.65 
Pancreas 1.34 ± 0.10 1.37 ± 0.10 1.62 ± 0.10 1.64 ± 0.13 1.59 ± 0.10 
Spleen 1.15  0.04 1.04 ± 0.05 1.00 ± 0.11 0.94 ± 0.04* 1.10 ± 0.05 
Adrenal 0.03 ± 0.00 0.04 ± 0.00 0.03 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 
Kidney 1.72 ± 0.04 1.65 ± 0.03 1.56 ± 0.04* 1.64 ± 0.04 1.86 ± 0.05* 
Testis 1.98 ± 0.41 2.03 ± 0.02 1.91 ± 0.05 2.03 ± 0.03 2.03 ± 0.06 
Epididymis 0.81 ± 0.02 0.80 ± 0.03 0.82 ± 0.02 0.86 ± 0.03 0.83 ± 0.01 
Values are expressed as mean ± S.E.M., n = 10. 
Satellite: a group was treated with oral dose of 1,200 mg/kg body weight/day for 270 days following by no treatment for 28 days. 
* Significantly different from control, p<0.05. 
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Discussion  
 
The single oral high dose of TB extract (5,000 mg/kg) in acute toxicity test did not show any toxicity signs or no 
significant differences in body weight, internal organ weight, and general behaviors in female and male SD rats. Furthermore, 
gross and pathological examinations of the internal organs revealed no pathological abnormality. The results suggest that the 
TB extract is virtually not toxic after an acute exposure in rats. 
In chronic toxicity study for 270 days, both female and male rats were treated with TB extract at all three doses (300, 600, 
and 1,200 mg/kg body weight. All rats at each dosage presented no signs of behavior changes, toxic signs and mortalities.  
The female treated groups revealed no significant differences in body weight gain and internal organ weight. In contrast, the 
body weight gain of male treated groups at all doses was significantly lower than control groups. However, the affected of 
body weight and body weight gain may result from physiological changes such as decrease, increase food intake, and 
metabolism. The result from animal health monitoring in the entire period of 270 days showed no sign of morbidity or 
diseases. Moreover, both female and male rats were healthy as shown by the normal appearance of general behavior, 
respiratory pattern, cardiovascular signs, motor activities, reflexes, and normal change in skin and fur.  
Bone marrow may be one of the target sites for the adverse effects of test substances. The hematological values were thus 
assessed in order to evaluate any toxic effects on function of bone marrow. White blood cell count was performed in order to 
evaluate immune system. In the present study, some hematological values in treated groups were significantly different from 
those of the control group such as red blood cells, hematocrit, MCV, MCHC, lymphocyte, monocyte, and eosinophil, but 
these values are within the normal ranges. These variations may result from normal variation among animal groups (Inala et 
al., 2002; Feldman et al., 2000). This finding suggests that the TB extract did not cause hematological or immunological 
defects.  
Blood chemical examination was used to evaluate any toxic effects on liver, kidney and pancreas. In our study, a 
significant difference of blood chemical values was observed in both female and male rats, but these blood chemical levels 
remained within the normal range (Angkhasirisap et al., 2002; Barry 1995). These results suggest that TB extract has no 
effect on liver, kidney and pancreas functions.  
Gross and pathological examinations of internal organs were performed to further confirm whether or not the 
organs or tissues had been damaged (Hayes, 2001). The results showed no macroscopic or microscopic changes in these 
internal organs or tissues in any treated rats, indicating that this test substance has no toxic effect.  
In conclusion, the water extract from the dried fruits of T. bellerica given orally to female and male rats did not produce both 
acute and chronic toxicities.  These data confirm that this water extract is safe for the rodent’s use. Further study regarding 
toxicology of this extract should be carried out in non-rodent or human in order to increase the confidence in their safety for 
the development of pharmaceutical products in the future. 
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